Neutrophil Biomarkers Can Predict Cardiotoxicity of Anthracyclines in Breast Cancer
International Journal of Molecular Sciences · 09.09.2024 · 25 (17) · 9735
DOI: 10.3390/ijms25179735 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 09.09.2024. Verfasst von Valentina K Todorova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology/Oncology, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Neutrophils, Anthracyclines, Cardiotoxicity. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lyon Cardiovascular Research Program, Institute on Aging, UAMS and resources within the Pharmacogenomics Analysis Laboratory, Research Service, Central Arkansa…, Lyon Cardiovascular Research Program, Institute on Aging, UAMS and resources within the Pharmacogenomics Analysis Laboratory.
Abstract (Originalsprache)
Doxorubicin (DOX), a commonly used anticancer agent, causes cardiotoxicity that begins with the first dose and may progress to heart failure years after treatment. An inflammatory response associated with neutrophil recruitment has been recognized as a mechanism of DOX-induced cardiotoxicity. This study aimed to validate mRNA expression of the previously identified biomarkers of DOX-induced cardiotoxicity, PGLYRP1, CAMP, MMP9, and CEACAM8, and to assay their protein expression in the peripheral blood of breast cancer patients. Blood samples from 40 breast cancer patients treated with DOX-based chemotherapy were collected before and after the first chemotherapy cycle and > 2 years after treatment. The protein and gene expression of PGLYRP1/Tag7, CAMP/LL37, MMP9/gelatinase B, and CEACAM8/CD66b were determined using ELISA and reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Receiver operating characteristic (ROC) curve analysis was used to determine the diagnostic value of each candidate biomarker. Patients with cardiotoxicity (n = 20) had significantly elevated levels of PGLYRP1, CAMP, MMP9, and CEACAM8 at baseline, after the first dose of DOX-based chemotherapy, and at > 2 years after treatment relative to patients without cardiotoxicity (n = 20). The first dose of DOX induced significantly higher levels of all examined biomarkers in both groups of patients. At > 2 years post treatment, the levels of all but MMP9 dropped below the baseline. There was a good correlation between the expression of mRNA and the target proteins. We demonstrate that circulating levels of PGLYRP1, CAMP, MMP9, and CEACAM8 can predict the cardiotoxicity of DOX. This novel finding may be of value in the early identification of patients at risk for cardiotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hematology/Oncology, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
- Department of Geriatrics, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
- Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
- Central Arkansas Veterans Healthcare System, Little Rock, AR 72205, USA.
- Department of Mathematics and Statistics, University of Arkansas at Little Rock, Little Rock, AR 72205, USA.
ORCID-Profile: Annjanette Stone, Sindhu J Malapati
Förderung
- Lyon Cardiovascular Research Program, Institute on Aging, UAMS and resources within the Pharmacogenomics Analysis Laboratory, Research Service, Central Arkansa…
- Lyon Cardiovascular Research Program, Institute on Aging, UAMS and resources within the Pharmacogenomics Analysis Laboratory
Zitieren
APA
Todorova, V. K., Azhar, G., Stone, A., Malapati, S. J., Che, Y., Zhang, W., Makhoul, I., & Wei, J. Y. (2024). Neutrophil Biomarkers Can Predict Cardiotoxicity of Anthracyclines in Breast Cancer. International Journal of Molecular Sciences, 25(17), 9735. https://doi.org/10.3390/ijms25179735
Vancouver
Todorova VK, Azhar G, Stone A, Malapati SJ, Che Y, Zhang W, et al. Neutrophil Biomarkers Can Predict Cardiotoxicity of Anthracyclines in Breast Cancer. International Journal of Molecular Sciences. 2024;25(17):9735. doi:10.3390/ijms25179735
BibTeX
@article{Todorova2024,
author = {Todorova, Valentina K and Azhar, Gohar and Stone, Annjanette and Malapati, Sindhu J and Che, Yingni and Zhang, Wei and Makhoul, Issam and Wei, Jeanne Y},
title = {Neutrophil Biomarkers Can Predict Cardiotoxicity of Anthracyclines in Breast Cancer},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {17},
pages = {9735},
doi = {10.3390/ijms25179735}
}
EUVIMED